A Cost-Effectiveness Analysis of Clopidogrel for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China
Crossref DOI link: https://doi.org/10.1007/s12325-016-0375-9
Published Online: 2016-07-11
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cui, Ming
Tu, Chen Chen
Chen, Er Zhen
Wang, Xiao Li
Tan, Seng Chuen
Chen, Can http://orcid.org/0000-0002-9109-1061
Funding for this research was provided by:
Sanofi China
License valid from 2016-07-11